A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot-Marie-Tooth disease type 1.

Kim H, Choi B-O, Lee H J, Park S, Lim J, Jung S-C

Stem Cells Transl Med. 2026 Jul 20; 15(8). PMID: 42522265. Abstract